期刊文献+

提高宫颈癌术后生存率的临床分析 被引量:7

原文传递
导出
摘要 目的研究在宫颈癌根治术同时行术中髂内动脉化疗,旨在减少宫颈癌术后复发,提高5年生存率和生活质量。方法自1995年9月-2005年9月,对36例ⅠB期和ⅡA期宫颈癌行根治术,按是否术中髂内动脉化疗分成A组和B组。A组18例,分别从右、左髂内动脉注入浓度为0.06%的顺铂各40mg,而后再行淋巴结清扫及广泛子宫切除术。B组直接行清扫术。比较它们术后并发症和生存率。结果两组术后均无严重并发症。A组和B组复发率为0和27.7%,5年生存率100%和83%,P<0.05。结论ⅠB~ⅡA宫颈癌根治术中髂内动脉同步化疗,术中、术后无严重并发症、可以减少复发、提高5年生存率和生活质量。此法值得提倡。
作者 卢珍
出处 《中华全科医学》 2011年第9期1411-1412,共2页 Chinese Journal of General Practice
  • 相关文献

参考文献13

二级参考文献62

  • 1王平,彭芝兰,张家文,刘辉,张崇淑,曹泽毅.子宫颈癌新辅助化疗中不同化疗途径的疗效比较[J].中华妇产科杂志,2005,40(4):227-230. 被引量:109
  • 2吴晶涛,赵永生,王田蔚,杨海山,安东洪.介入治疗对宫颈癌微血管密度的影响[J].中国临床医学影像杂志,2005,16(10):581-583. 被引量:6
  • 3刘萍,陈春林,曾北蓝,马奔,张浩.宫颈癌术前动脉化疗的组织病理学动态变化及临床结局[J].中国实用妇科与产科杂志,2006,22(2):109-111. 被引量:52
  • 4李庆水,张锡芹,李大鹏,盛修贵,杜雪莲,宋趣清.子宫颈癌放疗前新辅助化疗的临床研究[J].中华妇产科杂志,2006,41(2):83-87. 被引量:27
  • 5格林尼FL,佩基DL,弗莱明ID,et al.AJCC癌症分期手册[M].第6版.沈阳:辽宁科学技术出版社,2005:166.
  • 6Neoadjuvant Chemotherapy for Cervical Cancer Metaanalysis Collaboration(NACCCMA) Collaboration. Neoadjuvant chemotherapy for locally advanced cervix cancer [ M/CD ]. Cochrane Database Syst Rev,2004, (2) :CD001774.
  • 7Cormio G, Loizzi V, Carriero C. Is there a role for neoadjuvant chemotherapy in early invasive cervical carcinoma? [J]. Eur J Gynaecol Oncol, 2009,30 ( 3 ) :249-254.
  • 8Eddy G, Bundy B, CreasmanW, et al. Treatment of (bulky) stage Ⅰb cervical cancer with or without neoadjuvant vincristine and cisplatin prior'to radical surgery and pelvic/para-aortic lymphadenectomy:a phase Ⅲ trial of the gynecologic oncology group [J]. Gynecol Oncol,2007, 106(2) :362- 369.
  • 9Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer:results from the Italian muhicenter randomized study [J]. J Clin Oncol,2002,20 (1) :179-188.
  • 10Souhami L, Gill RA, Allan SR, et al. A randomized trial of chemotherapy followed by radiation therapy in stage m B carcinoma of the cervix[J]. JCO, 1991,9(6) :970-977.

共引文献144

同被引文献70

  • 1刘萍,陈春林,曾北蓝,马奔,张浩.宫颈癌术前动脉化疗的组织病理学动态变化及临床结局[J].中国实用妇科与产科杂志,2006,22(2):109-111. 被引量:52
  • 2张杰,吕蔡,张平安,詹炳炎,余小祥.槲皮素抑制人宫颈癌HeLa细胞增殖的实验研究[J].中国肿瘤临床,2006,33(8):436-438. 被引量:18
  • 3Plentl A A, Friedman E A. Lymphatic system of the female genitalia. The morphologic basis of oncologic diagnosis and therapy[J]. Major Probl Obstet Gynecol, 1971(2) : 1-223.
  • 4Williams A D, Cousins C, Soutter W P, et al. Detection of pel-ic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography[-J]. AJR,2001,177(2) :343-348.
  • 5Harry V N, Semple S I, Gilbert F J, et al. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cer-ical cancer[J]. Gynecol Oncol, 2008,111 (2) :213-220.
  • 6Chen J, Zhang Y, Liang B, et al. The utility of diffusion- weighted MR imaging in cer-ical cancer[J]. Eur J Radiol, 2010,74(3) : 101-106.
  • 7WHO. Word Health Organization report : Comprehensive cervicalcancer control : a guide to essential practice [ R]. World Health Or-ganization,2011.
  • 8Horn LC,Fischer U,Bilek K. Histoppathological prognostic factorsin primary surgically treated cercix carcinoma [ J]. Zentralbl Gyna-kol,2001,123(5) :266 -274.
  • 9刘光元.肿瘤血管介人治疗[M].南京:江苏科学技术出版社,2003:153.
  • 10Toita T,Sakumoto K,Higanshi M,et al. Therapeutic value of neoad-juvant intra - arterial chemotherapy ( cisplatin) and irradiation forlocally advanced uterine cervical cancer[ J]. Gynecol Oncol,2002,65(3) :4211.

引证文献7

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部